嗜酸性中耳炎的研究新进展
作者:
基金项目:

湖南省科技创新计划项目(2018SK52513)。


Research progress of eosinophilic otitis media
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    嗜酸性中耳炎(EOM)其显著特点是中耳腔中的黏液中含有大量的嗜酸性粒细胞,常合并支气管哮喘或变应性鼻炎。传统的治疗中耳炎的方法,如:鼓膜切开、抗生素消炎、乳突根治术等并不能取得良好的效果。经过临床治疗发现,全身或局部运用类固醇类激素及生物靶向治疗,效果显示优于传统治疗。因嗜酸性中耳炎相对少见,临床表现并不典型,发现时已经是较严重阶段,患者常错过最佳的治疗时期。本文对嗜酸性中耳炎的发病机制、临床表现、临床分型、影像学特点、诊断标准及治疗进行综述,以期提高对嗜酸性中耳炎的认识。

    Abstract:

    Eosinophilic otitis media (EOM) is characterized by a large amount of eosinophils in the mucus of the middle ear cavity, which is often associated with bronchial asthma or allergic rhinitis. Traditional methods of treating otitis media, such as tympanotomy, antibiotics anti-inflammatory, radical mastoidectomy, etc. can not achieve good results. Through clinical treatment, the effect of steroid hormones and biological targeted therapy systemically or locally is superior to that of traditional therapy. Eosinophilic otitis media is relatively rare and its clinical manifestations are not typical. Patients often miss the optimal treatment period when it is found in a relatively severe stage. This article reviews the pathogenesis, clinical manifestations, clinical classification, imaging features, diagnostic criteria and treatment of eosinophilic otitis media to improve the understanding of eosinophilic otitis media.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] 张靖仪, 郭颖梅, 农应全. 探讨过敏性鼻炎与渗出性中耳炎疾病发生关系[J]. 中国医学文摘(耳鼻咽喉科学), 2020,35(2):105-107.
    [2] Iino Y, Kakizaki K, Saruya S, et al. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry[J]. Arch Otolaryngol Head Neck Surg, 2006,132(10):1109-1114.
    [3] 刘斌, 苏亚, 冯晓辉. 嗜酸性中耳炎的研究现状[J]. 中华耳科学杂志, 2017,15(3):372-375.
    [4] Kudo N, Matsubara A, Nishizawa H, et al. Immunohistological analysis of eotaxin and RANTES in the model animal of eosinophilic otitis media[J]. Acta Otolaryngol, 2017,137(5):476-481.
    [5] Wang P, Zhou Y, Wang H, et al. A case of eosinophil otitis media with smear-negative middle ear effusion and literature review[J]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2020,34(5):465-467.
    [6] Uchimizu H, Matsuwaki Y, Kato M, et al. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media[J]. Allergol Int, 2015,64 Suppl:S18-S23.
    [7] Kanazawa H, Yoshida N, Iino Y. New insights into eosinophilic otitis media[J]. Curr Allergy Asthma Rep, 2015,15(12):76.
    [8] Bhutta MF, Lambie J, Hobson L, et al. Transcript analysis reveals a hypoxic inflammatory environment in human chronic otitis media with effusion[J]. Front Genet, 2019,10:1327.
    [9] Yang J, Zhao C, Chen P, et al. Morphological and pathological changes of Eustachian tube mucosa in an animal model of eosinophilic otitis media[J]. Braz J Otorhinolaryngol, 2020.
    [10] Varghese L, Philip A, Suryawanshi MK, et al. Eosinophilic otitis media-an otitis media mandating a different outlook[J]. Ear Nose Throat J, 2020:584318533.
    [11] Iino Y, Tomioka-Matsutani S, Matsubara A, et al. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease[J]. Auris Nasus Larynx, 2011,38(4):461.
    [12] Iino Y, Usubuchi H, Kodama K, et al. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media[J]. Otology Neurotology, 2010,31(1):100-104.
    [13] Iino Y. Eosinophilic otitis media:A new middle ear disease entity[J]. Current Allergy Asthma Reports, 2008,8(6):525-530.
    [14] Iino Y, Usubuchi H, Kodama K, et al. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma[J]. Otology Neurotology, 2008,29(7):949-952.
    [15] Zernotti ME, Pawankar R, Ansotegui I, et al. Otitis media with effusion and atopy:is there a causal relationship[J]. World Allergy Organ J, 2017,10(1):37.
    [16] Nagamine H, Iino Y, Kojima C, et al. Clinical characteristics of so called eosinophilic otitis media[J]. Auris Nasus Larynx, 2002,29(1):19-28.
    [17] Matsubara A, Nishizawa H, Kurose A, et al. An experimental study of inner ear injury in an animal model of eosinophilic otitis media[J]. Acta Otolaryngol, 2013,134(3):227-232.
    [18] Han YE, Yong SK, Cho Y, et al. Eosinophilic otitis media treated with anti-ige monoclonal antibodies and a bone conduction implant[J]. J Int Adv Otology, 2018,14(1):144-147.
    [19] De Loof M, De Leenheer E, Holtappels G, et al. Cytokine profile of nasal and middle ear polyps in a patient with Woakes' syndrome and eosinophilic otitis media[J]. BMJ Case Rep, 2016,2016:bcr2016215054.
    [20] Zhang YZ, Wei XY, Chen ZC, et al. Clinical diagnosis and treatment of eosinophilic otitis media[J]. J Clin Otorhinolaryngol, 2019,33(2):160-163.
    [21] Seo Y, Nonaka M, Pawankar R. Eosinophilic otitis media and comorbid asthma[J]. Curr Opin Allergy Clin Immunol, 2019,20(1):9-13.
    [22] Fukuda A, Morita S, Nakamaru Y, et al. Differentiation between eosinophilic otitis media and otitis media associated with eosinophilic granulomatosis with polyangiitis[J]. Otol Neurotol, 2019,40(8):e796-e802.
    [23] Masuda M, Esu Y, Iino Y, et al. Risk factors for bacterial infection to cause sensorineural hearing loss in eosinophilic otitis media[J]. Auris Nasus Larynx, 2020.doi:10.1016/j.anl.2020.08.001.[Online ahead of print].
    [24] Esu Y, Iino Y, Masuda M, et al. Proposal of a Treatment strategy for eosinophilic otitis media based on middle ear condition[J]. Otology Neurotol, 2018,39(8):e671-e678.
    [25] Chung WJ, Lee JH, Lim HK, et al. Eosinophilic otitis media:CT and MRI findings and literature review[J]. Korean J Radiol, 2012,13(3):363-367.
    [26] Saliba I, Alzahrani M, Weng X, et al. Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping[J]. Acta Otolaryngol, 2018,138(2):110-115.
    [27] Ueki S, Ohta N, Takeda M, et al. Eosinophilic otitis media:the aftermath of eosinophil extracellular trap cell death[J]. Curr Allergy Asthma Rep, 2017,17(5):33.
    [28] Yukako S, Manabu N, Yukie Y, et al. Optimal control of asthma improved eosinophilic otitis media[J]. Asia Pacific Allergy, 2018,8(1):e5.
    [29] Esu Y, Masuda M, Yoshida N. Periostin in middle愠瑥畡牲攠孭?嵣??佡琠潡汣?乯敲畤物潮瑧漠汴???は?ど???????散㈠???整?????扤物?嬠??嵶??楩畴特愺?呩???慥琠獥畡扲愠牰慡?????畧摹漭?乡??敤琠?慲汥??呭桥敮?敛硊灝爮攠獁獵楲潩湳?潎晡?瑵桳礠浌楡捲?獮瑸爬漠洲愰氲‰氬礴洷瀨栴漩瀺漵椲攷琭椵渳‵椮渼?灲愾瑛椳攰湝琠獌?慶湥摲?慒測椠浓慭污?浬潢摥敧汯獶?督椠瑁栬?敐潡獧楥渠潃瀠桐椮氠楌捯?潡瑬楬瑹椠獡?浡敩摬楡慢孬?崠???捡瑲慩?传瑭潯汤慵牬祡湴来潳氠???ぬ???????????????????扩牴?孥??崠??愠牡愠?剡???畲搠潩?乤??卥畮穤略歮楴?卯??敡瑮?慩汣??????据????摴敩湶摩牴楹瑛楊捝?挠故汵汲猠?挠潐敨硡灲牭敡獣獯楬測朠′琰栱礰洬椶挳‰猨琱爭漳洩愺氱″氷礭洱瀴栴漮瀼潢楲放瑛椳渱?爠敔捨敥灯瑨潡牲?楤湥?愠湔楃洬愠汔?浩潬摩敯汮?漠晉?攠潃獯楮湴潩瀠桐椮氠楍捡?潴琠楣瑥楬獬?洠敭摡楹愠孲?嵧???獴楥愠?偨慥挠??汴汩攭物杮祦???ね?ぴ??べ????敩????戠牯?嬠??崭″?楛湊潝?夠??却攠歊椠湍敯?夠??奩漬猠栲椰搱愹?匲??攱琵?愺氳?‰?甮瀼楢汲甾浛愳戲?琠桉敳牨慩灺祵?晡漠牔?瀠慍瑡楴敳湵瑩猠?眬椠瑏桫?牭敯晴牯愠捙琬漠牥祴?敡潬献椠湒潡灭桡楴汲楯换?潮琠椨瑂楁獙?浵攠搳椴愰‵愩猺獡漠据楯慶瑥敬搠?睵楡瑬栠?扮牴潡湧捯桮楩慳汴?慯獦琠桔浘慁嬲?嵲???異牴楯獲?乡慮獤甠獃??慨爲礬渠硡???ぷ?べ?摩潤楥??ど??づ???橲?慳湴污??ち?つ?の??????季佥湰汴楯湲敛?慝栮攠慃摡?潤晩?灶牡楳湣琠嵄??执爠?孥??崠′?眰愴猬愲欲椨′匩??丱愭朹田爮愼?????椳穝甠瑗慡?????漠捕桥汭敡慥牴?業浡灲汩愠湉琬愠瑍極潲湡?楨湩?慡?灈愬琠楥整渠瑡?眮椠瑓桵?散潥獳楳湦潵灬栠楴汲楥捡?潭瑥楮瑴椠獯?洠敥摯楳慩孮?嵰???畩牣??牴捩桴?佳琠潭牥桤楩湡漠汵慳物祮湧朠潲污???ひは??????????????????扣牡?孥??嵊?匮甠杁極浲潩瑳漠?????愠瑌慡湲潹????串漰搰愶????攴琩?愴氶???潢捲栾汛攳愴牝?槑淲瀬氠慅湵瑮愠瑙楯潮湧?楇湹?搬攠慙景?瀠慓瑵楮敧渠瑇獥?睮椮琠棇?攧漻玎椨渗濺瀧栭椳沎槑挟?澄瑜椨璢榨獛?浝攮搠椭懽※畯猇楗測朠′猰由戶琬漱琴愨氲?瀩攺琷爱漭猷攲挮琼潢浲社?愳渵摝?浃慲獩瑳潡楦摵?潬扩氠楇琬攠牃慡瑭楩潮湩孴?崠???畃牨??牲捡栠?伬琠潥牴栠楡湬漮氠慏牭祡湬杩潺汵???????????????ㄠ????ㄠ????扲牥?孡??嵥??獩畣?奤??呥慡浳楥椺?匠???慥猠畳摥慲????敊瑝?愠汉???映晊攠捐瑥楤癩敡湴敲猬猠′漰昱?洬礴爵椨渱朩漺瀱氳愮猼瑢祲 ̄楛渳?灝愠瑏楫敵湤瑥猠?眬椠瑔桡?敡潹獡椠湅漬瀠桋楯汮楤捯?潍琬椠瑥楴猠?浬攮搠楁愠季?嵳???畦爠楳獥?乥慲獥甠獡??慨牭祡渠硷?????は?摩潮楯??ど??っㄠ??橩?慩湳氠??つ?ち?び??っづ??学併湬汬楹渠整?慥桡整慥摤?潷晩?灨爠楡湮瑴嵩?ige monoclonal antibody omalizumab[J]. Case Rep Pulmonol, 2012,2012:340525.
    [37] Iino Y, Hara M, Hasegawa M, et al. Clinical efficacy of anti-ige therapy for eosinophilic otitis media[J]. Otology Neurotol, 2012,33(7):1218-1224.
    [38] Iino Y, Takahashi E, Ida S, et al. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media[J]. Auris Nasus Larynx, 2019,46(2):196-203.
    [39] Isao S, Yurika K, Akihiko T, et al. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab[J]. Auris Nasus Larynx, 2018:S2000075464.
    [40] Chow K, Cosetti MK. Use of il-5 inhibitor benralizumab as a novel therapy for eosinophilic otitis media:clinical capsule and review of liter
    引证文献
引用本文

胡民强,刘伟,伍伟景,邓健航.嗜酸性中耳炎的研究新进展[J].中国耳鼻咽喉颅底外科杂志,2021,27(1):109-113

复制
分享
文章指标
  • 点击次数:65
  • 下载次数: 313
历史
  • 收稿日期:2020-11-01
  • 在线发布日期: 2021-03-04
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭